Basis: FMP quote price / unrounded FMP forward EPS in the trading currency, available after its recorded retrieval time. Source: stored company filings and market data; unavailable inputs remain N/A.
The forward PE ratio is 10.87 as of 2026-10-06T14:01:32.392Z.
Consensus retrieved: 2026-10-06T11:16:20.015Z. This records retrieval, including cache reads, rather than vendor publication. The calculation uses the separately dated price and estimate available at its as-of time.
Calculation as of: 2026-10-06T14:01:32.392Z.
Quote observation: 2026-10-06T13:59:14.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: c8d7801cb5d69976804150322740a3f9972799eb944d256c77d6faa31d53dc8f
Forward PE Ratio (10.87) = Dated Quote Price ($17.40) / Consensus Forward EPS ($1.60)
FORWARD PE RATIO
10.87
SECTOR MEDIAN · HEALTHCARE
19.45
median of 148 covered companies
CURRENT VS SECTOR MEDIAN
-44.13%
vs the sector median at left
EUDA Health Holdings Limited
Market Cap
$32.50M
Forward PE Ratio
10.87
| NAME | MARKET CAP | FORWARD PE RATIO |
|---|---|---|
| EUDA Health Holdings Limited (EUDA) | $32.50M | 10.87 |
| Context Therapeutics Inc. (CNTX)vs › | $32.36M | N/A |
| MIRA Pharmaceuticals, Inc. (MIRA)vs › | $32.24M | N/A |
| HeartBeam, Inc. (BEAT)vs › | $33.30M | N/A |
| BeyondSpring Inc. (BYSI)vs › | $31.39M | N/A |
| Baird Medical Investment Holdings Limited (BDMD)vs › | $31.23M | 9.25 |
| MDxHealth S.A. (MDXH)vs › | $30.89M | N/A |
| Aligos Therapeutics, Inc. (ALGS)vs › | $34.22M | N/A |
| Grace Therapeutics, Inc. (GRCE)vs › | $34.50M | N/A |
| CervoMed Inc. (CRVO)vs › | $29.44M | N/A |
Trailing P/E
N/A
reported TTM EPS
Forward P/E
10.9
consensus EPS · fiscal year ending 2026-12-31
At the dated quote price of $17.40, each upcoming fiscal year's consensus EPS implies a different multiple — how quickly the price is "paid down" by expected earnings if the estimates hold.
| Fiscal year end | Consensus EPS | Estimate range | Analysts | Implied P/E |
|---|---|---|---|---|
| 2026-12-31 | $1.60 | $1.60 – $1.60 | 1 | 10.9x |
Source: FMP analyst consensus estimates, refreshed with the daily precompute. "n/m" = the consensus EPS is not positive, so a multiple is undefined. There is no forward P/E history chart here because charting one would require the estimates as they stood in the past, which we do not store — see the trailing P/E history for how the realized multiple has moved.
PE Ratio = Share Price / Diluted EPS (TTM)
The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
